Reagan Jarvis

Reagan Jarvis

Company: Anocca

Job title: Chief Executive Officer


Panel Discussion: Discovering New TCRs: What Defines a “Good” TCR? 12:30 pm

• Reviewing the characteristics that define a good TCR • Optimising stringency and potency without minimising TCR target specificity • Exploring the challenges, risks, and potentials of TCRs in the future of cell therapy therapeuticsRead more

day: Day 2 - Track A - Morning

Case Study: Mapping & Validating Target Antigens for TCR Therapeutics 11:00 am

• Undertaking deep and quantitative mapping of HLA-restricted peptides from tumour-expressed sequences • Conducting rapid multiplexed discovery of TCRs from naïve human repertoire • Exploring the results from rapid cell-based characterisation and validation of HLA-restricted peptides with candidate TCR reagentsRead more

day: Day 2 - Track A - Morning

Leveraging Innovative Technology to Enhance Cell Function & Improve Therapeutic Efficacy
10:50 am

Read more

day: Day 1 - Track A - Morning

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.